Read the latest article selected by the ERS publications team: Pirfenidone exacerbates Th2-driven vasculopathy in a moues model of systemic sclerosis-associated interstitial lung disease. Read the article in full in the European Respiratory Journal, the most highly regarded peer-reviewed respiratory journal in Europe with an impact factor of 33.795.
No comments:
Post a Comment